GSK, Human Genome in co-development project

07/8/2005 | American City Business Journals

GlaxoSmithKline plans to co-develop a rheumatoid arthritis drug being tested by Human Genome Sciences. GSK said it would exercise its co-development option under a 1996 agreement between the two firms, with both companies sharing the costs of late-stage clinical trials and marketing costs if the drug is commercialized.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel, Regulatory (FDA)
CareFusion
San Diego , CA
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations